Developing a Breast Cancer Screening Program in Nigeria: Evaluating Current Practices, Perceptions, and Possible Barriers

Autor: Olalekan Olasehinde, Carla Boutin-Foster, Olusegun I. Alatise, Adewale O. Adisa, Oladejo O. Lawal, Akinbolaji A. Akinkuolie, Abdul-Rasheed K. Adesunkanmi, Olujide O. Arije, Thomas P. Kingham

Publikováno v: Journal of Global Oncology, Vol 3, Iss 5, Pp 490-496 (2017)

Purpose: In low- and middle-income countries like Nigeria, women present with advanced breast cancer at an earlier age. Given the limited resources, development of screening programs that parallel resource capabilities of low- and middle-income count

Externí odkaz: https://doaj.org/article/cfccdc094fee4f52b8a306abb90ee933

Breast cancer patients' presentation for oncological treatment: a single centre study

Autor: Akinbolaji Andrew Akinkuolie, Olalekan Olasehinde, Olukayode Adeolu Arowolo, Rereloluwa Nicodemus Babalola

Publikováno v: The Pan African Medical Journal, Vol 24, Iss 63 (2016)

Introduction: breast cancer patients are presenting at advanced stages for oncological treatment in Nigeria and World Health Organization predicted developing countries incidence and mortality to increase by year 2020.Methods: prospective observation

Externí odkaz: https://doaj.org/article/b7f9b99aca004d438d25b3266f6fcc66

Neo‐adjuvant Capecitabine Chemotherapy in Women with Newly Diagnosed Locally Advanced Breast Cancer in a Resource‐poor Setting (Nigeria): Efficacy and Safety in a Phase II Feasibility Study

Autor: Gini F. Fleming, Chinedum P. Babalola, Helen Oduntan, Adebayo Victor Adetiloye, Akinbolaji A. Akinkuolie, Hae Kyung Im, Adesunkanmi AbdulRasheed Kayode, Kayode A. Adelusola, Oyewale Abidoye, Augustine E Agbakwuru, Olufunmilayo I. Olopade, Olukayode O. Lawal, Adeyinka G. Falusi, Olusola C. Olopade, Muheez A. Durosinmi, Millicent Olubunmi Obajimi, Temidayo O. Ogundiran, Uchenna O. Njiaju, A O Oluwasola, Olukayode Arowolo

Publikováno v: The Breast Journal

The majority of clinical trials of neo-adjuvant therapy for breast cancer have been conducted in resource-rich countries. We chose Nigeria, a resource-poor country, as the major site for a phase II feasibility open-label multicenter clinical trial de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10dd7275718f5fdd2d372c8c00d81ad6
https://doi.org/10.1111/tbj.12149

Recurrent inguinal hernia in Ile-Ife Nigeria: Characteristics and outcome of management

Autor: A C Etonyeaku, Ademola Olusegun Talabi, E A Agbakwuru, Funmilola Wuraola, Akinbolaji A. Akinkuolie, Olalekan Olasehinde, Adedapo O Kolawole

Publikováno v: Nigerian Journal of Surgical Sciences. 26:33

Background: There are very few reports addressing patients' characteristics, patterns, and outcome of treatment of recurrent inguinal hernia irrespective of the method of hernia repair. Purpose: The purpose of this study is to evaluate the patients a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b33d1f93fb17ed12b2a122e38627e6de
https://doi.org/10.4103/njss.njss_7_16

Contemporary management of breast cancer in Nigeria: Insights from an institutional database.

Autor: Olasehinde O; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Alatise O; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Omisore A; Department of Radiology, Obafemi Awolowo University/ Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Wuraola F; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Odujoko O; Department of Morbid Anatomy and Forensic pathology, Obafemi Awolowo University / Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Romanoff A; Breast Surgery, Dubin Breast Center, Icahn School of Medicine at The Mount Sinai Hospital, New York, New York, USA.; Department of Health System Design and Global Health, Icahn School of Medicine at The Mount Sinai Hospital, New York, New York, USA., Akinkuolie A; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Arowolo O; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Adisa A; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Knapp G; Department of Oncology, Division of Surgical Oncology, University of Calgary, Alberta, Canada., Famurewa O; Department of Radiology, Obafemi Awolowo University/ Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Omisile I; Department of Psychology, Faculty of Social Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria., Onabanjo E; African Research Group for Oncology, OAUTHC, Ile-Ife, Nigeria., Constable J; Department of Surgery, Memorial Sloan-Kettering Cancer center, New York., Omoniyi-Esan G; Department of Morbid Anatomy and Forensic pathology, Obafemi Awolowo University / Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Adesunkanmi AR; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Lawal O; Department of Surgery, Obafemi Awolowo University/Obafemi Awolowo University Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria., Kingham TP; Department of Surgery, Memorial Sloan-Kettering Cancer center, New York.

Publikováno v: International journal of cancer [Int J Cancer] 2021 Jun 15; Vol. 148 (12), pp. 2906-2914. Date of Electronic Publication: 2021 Feb 09.